ANGELO BRUTICO: Open Payments
NPI 1285286021 · SCRANTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 34 payments from 14 companies in 2025. Trend: 2023 $575 · 2024 $589 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $199 |
| Tandem Diabetes Care, Inc. | 3 | $97 |
| Indivior Inc. | 3 | $62 |
| Eisai Inc. | 2 | $61 |
| Alkermes, Inc. | 2 | $43 |
| PFIZER INC. | 2 | $41 |
| Dexcom, Inc. | 2 | $37 |
| Braeburn Inc. | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Gilead Sciences, Inc. | 1 | $20 |
Products named: VRAYLAR, t:slim X2 Insulin Pump with Control-IQ, SUBLOCADE, Leqembi, QULIPTA, VIVITROL, PREVNAR 20, Dexcom G6 Transmitter.
Industry payments across PA — which companies pay providers there.
